Search Results - Sandro Pignata

Refine Results
  1. 1

    Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey by Michele Mongelli, Domenica Lorusso, Vanna Zanagnolo, Sandro Pignata, Nicoletta Colombo, Gennaro Cormio

    Published in Diagnostics (2024-05-01)
    Get full text
    Article


  2. 2

    Patient and public involvement in research: a survey on experience, opinions and training needs of gynecologic oncologists in two collaborative groups in Italy by Cinzia Colombo, Pasquale Paletta, Antonella Savarese, Sandro Pignata, Paola Mosconi, Elena Biagioli

    Published in Research Involvement and Engagement (2025-03-01)
    Get full text
    Article


  3. 3

    PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts? by Elisena Franzese, Anna Diana, Sara Centonze, Sandro Pignata, Ferdinando De Vita, Fortunato Ciardiello, Michele Orditura

    Published in Frontiers in Oncology (2020-06-01)
    Get full text
    Article


  4. 4

    Myoid gonadal stromal tumor, a case report with review of the literature by Giuseppe D'Abbronzo, Andrea Ronchi, Maria Paola Belfiore, Elvira La Mantia, Florinda Feroce, Sandro Pignata, Sisto Perdonà, Renato Franco

    Get full text
    Article


  5. 5

    Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report by Anna Passarelli, Carmela Pisano, Elisabetta Coppola, Jole Ventriglia, Sabrina Chiara Cecere, Marilena Di Napoli, Luciano Carideo, Secondo Lastoria, Sandro Pignata

    Published in Frontiers in Immunology (2023-12-01)
    Get full text
    Article


  6. 6

    Physicians’ Controversies Towards Fertility Preservation in Young Patients with Gynecological Cancer: An MITO Survey by Giacomo Corrado, Inge Peters, Erica Silvestris, Raffaella Cioffi, Marcello Iacobelli, Emanuela Mancini, Riccardo Vizza, Sofia Thiella, Gennaro Cormio, Sandro Pignata, Giorgia Mangili

    Published in Current Oncology (2025-09-01)
    Get full text
    Article


  7. 7

    Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy by Ernesta Cavalcanti, Vittoria Barchiesi, Dionigio Cerasuolo, Flaviano Di Paola, Monica Cantile, Sabrina Chiara Cecere, Sandro Pignata, Alessandro Morabito, Raffaele Costanzo, Massimo Di Maio, Francesco Perrone

    Published in Analytical Cellular Pathology (2016-01-01)
    Get full text
    Article


  8. 8

    Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators by Marco Stellato, Giuseppe Procopio, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Alessia Mennitto, Andrea Sbrana, Giandomenico Roviello, Chiara Casadei, Pierangela Sepe, Sandro Pignata, Daniele Santini

    Published in Journal of Translational Medicine (2021-08-01)
    Get full text
    Article


  9. 9

    The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer by Anna Passarelli, Jole Ventriglia, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti, Rosa Tambaro, Luca Tarotto, Francesco Fiore, Alberto Farolfi, Michele Bartoletti, Sandro Pignata

    Published in Frontiers in Oncology (2023-01-01)
    Get full text
    Article


  10. 10

    Ovarian Cancer Radiosensitivity: What Have We Understood So Far? by Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, Andrei Fodor, Emanuela Rabaiotti, Giorgio Candotti, Simona Secondino, Angelica Facoetti, Laura Deborah Locati, Sandro Pignata, Ester Orlandi, Giorgia Mangili

    Published in Life (2022-12-01)
    Get full text
    Article


  11. 11

    Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience by Dario Franzese, Antonio Tufano, Alessandro Izzo, Raffaele Muscariello, Giovanni Grimaldi, Giuseppe Quarto, Luigi Castaldo, Sabrina Rossetti, Savio Domenico Pandolfo, Sonia Desicato, Paola Del Prete, Matteo Ferro, Sandro Pignata, Sisto Perdonà

    Published in Asian Journal of Urology (2023-10-01)
    Get full text
    Article


  12. 12

    The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. by Daniela Russo, Anna Spina, Luigi Portella, Anna Maria Bello, Francesca Galdiero, Anna Maria Trotta, Caterina Ieranò, Giuseppina Rea, Sabrina Chiara Cecere, Elisabetta Coppola, Salvatore Di Maro, Sandro Pignata, Daniela Califano, Stefania Scala

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  13. 13

    International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study) by Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti

    Published in BMC Cancer (2024-06-01)
    Get full text
    Article


  14. 14

    Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer by Anna Passarelli, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Sabrina Rossetti, Rosa Tambaro, Jole Ventriglia, Federica Gherardi, Eva Iannacone, Sergio Setola Venanzio, Francesco Fiore, Michele Bartoletti, Giosuè Scognamiglio, Daniela Califano, Sandro Pignata

    Published in Frontiers in Immunology (2022-09-01)
    Get full text
    Article


  15. 15

    Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma by Domenica Lorusso, Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Laura Deborah Locati, Gianluca Masi, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo, Nicoletta Colombo

    Published in Frontiers in Oncology (2023-08-01)
    Get full text
    Article


  16. 16

    Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma by Domenica Lorusso, Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Laura Deborah Locati, Gianluca Masi, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo, Nicoletta Colombo

    Published in Frontiers in Oncology (2022-09-01)
    Get full text
    Article


  17. 17

    The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group by Martina Arcieri, Sandro Pignata, Domenica Lorusso, Domenica Lorusso, Anna Fagotti, Anna Fagotti, Vito Chiantera, Antonino Ditto, Giorgio Valabrega, Claudia Marchetti, Claudia Marchetti, Claudio Zamagni, Valentina Tuninetti, Alberto Farolfi, Stefano Restaino, Stefano Restaino, Giuseppe Vizzielli, Giuseppe Vizzielli

    Published in Frontiers in Oncology (2026-05-01)
    Get full text
    Article


  18. 18

    Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type by Roberto Buonaiuto, Roberto Buonaiuto, Giuseppe Neola, Aldo Caltavituro, Aldo Caltavituro, Alessandra Longobardi, Federica Pia Mangiacotti, Amedeo Cefaliello, Maria Rosaria Lamia, Francesco Pepe, Jole Ventriglia, Umberto Malapelle, Giancarlo Troncone, Mario Giuliano, Grazia Arpino, Sandro Pignata, Carmine De Angelis

    Published in Frontiers in Oncology (2024-09-01)
    Get full text
    Article


  19. 19

    Pazopanib in metastatic renal cancer: a “real-world” experience at National Cancer Institute “Fondazione G. Pascale” by Sabrina Chiara Cecere, Sabrina Rossetti, Carla Cavaliere, Chiara Della Pepa, Marilena Di Napoli, Anna Crispo, Gelsomina Iovane, Raffaele Piscitelli, Domenico Sorrentino, Gennaro Ciliberto, Piera Maiolino, Paolo Muto, Sisto Perdonà, Massimiliano Berretta, Sandro Pignata, Gaetano Facchini, Carmine D'Aniello

    Published in Frontiers in Pharmacology (2016-08-01)
    Get full text
    Article


  20. 20

    Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial by Valentina Borzillo, Esmeralda Scipilliti, Donato Pezzulla, Marcello Serra, Gianluca Ametrano, Giuseppe Quarto, Sisto Perdonà, Sabrina Rossetti, Sandro Pignata, Anna Crispo, Piergiacomo Di Gennaro, Valentina D’Alesio, Cecilia Arrichiello, Francesca Buonanno, Simona Mercogliano, Antonio Russo, Antonio Tufano, Rossella Di Franco, Paolo Muto

    Published in Frontiers in Oncology (2023-11-01)
    Get full text
    Article


Search Tools: